Busulfan-based reduced toxicity conditioning regimen used in hematopoietic stem cell transplantation in HLH patients results in sustained donor chimerism

Pediatr Hematol Oncol. 2021 May;38(4):410-416. doi: 10.1080/08880018.2020.1868638. Epub 2021 Feb 24.

Authors

Erin Goode¹, Holly Miller^{1

2}, Dana Salzberg¹, Courtney Campbell¹, Kristen Beebe^{1

2}, Charlotte Schwalbach¹, Roberta H Adams^{1

2}, Alexander Ngwube^{1

2}

Affiliations

¹ Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ, USA.
² Mayo Clinic Arizona, Phoenix, AZ, USA.

PMID: 33625293
DOI: 10.1080/08880018.2020.1868638

No abstract available

Publication types

Letter
Comment

MeSH terms

Busulfan*
Chimerism
Hematopoietic Stem Cell Transplantation*
Humans
Transplantation Conditioning

Substances

Busulfan